Summary & Overview
CPT 0696T: Body Surface Activation Mapping for Biventricular Pacing
CPT code 0696T defines a noninvasive mapping and programming service that uses body surface–activation mapping (for example, multiple‑lead ECG) to optimize electrical synchrony of biventricular pacing or biventricular pacing–defibrillator systems at the time of follow‑up device interrogation. This code addresses a growing clinical need as cardiac resynchronization therapy becomes more common for patients with dyssynchronous ventricular contractions; optimization at follow‑up can affect symptoms, device performance, and downstream utilization. Key national payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent of the service, typical sites of service, and the service type; an overview of how payers approach coverage and coding for device optimization services; and references to common modifiers and operational considerations. The publication also provides benchmarking context and policy highlights relevant to hospitals, device clinics, and electrophysiology practices. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 0696T describes the use of body surface–activation mapping, for example with multiple‑lead electrocardiography, to optimize electrical synchrony of a biventricular pacing or biventricular pacing–defibrillator system during a follow‑up interrogation or programming evaluation. The procedure’s goal is to restore electrical synchrony in dyssynchronous ventricles that are not contracting in coordinated fashion due to erratic electrical impulses.
Service type: Device programming and noninvasive electrophysiologic mapping to optimize cardiac resynchronization therapy.
Typical site of service: Hospital outpatient department, cardiac device clinic, or specialized electrophysiology clinic.
Clinical & Coding Specifications
Clinical Context
A 72-year-old male with ischemic cardiomyopathy and symptomatic heart failure (NYHA class III) presents for routine device follow-up after implantation of a cardiac resynchronization therapy–defibrillator (CRT‑D). The patient reports persistent exertional dyspnea and fatigue despite guideline-directed medical therapy. Device interrogation shows intact leads and appropriate sensing/thresholds, but transthoracic echocardiography demonstrates interventricular dyssynchrony with wide QRS complex. The electrophysiology team performs body surface–activation mapping using a multiple‑lead ECG system at the time of a scheduled device programming evaluation to optimize ventricular pacing timing and restore electrical synchrony.
The clinical workflow includes pretest review of prior device settings and recent imaging, patient consent, preparation and placement of multi‑lead body surface electrodes, acquisition of activation maps during intrinsic rhythm and paced rhythms, analysis to identify optimal atrioventricular and interventricular delays, intra‑procedural reprogramming of the biventricular pacing parameters, and post‑programming device interrogation to confirm improved electrical synchrony and capture thresholds. The typical site of service is an outpatient electrophysiology device clinic or an ambulatory procedure area within a hospital where device programming and noninvasive mapping equipment are available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |